BSc (Hons) Genetics, MSc Medical Microbiology and Infectious Diseases, PhD Medicine

Dr Rae-Anne Hardie joined the Centre for Health Systems and Safety Research in April 2016. Her current areas of research focus on Primary Care and General Practice, and gathering feedback from hospital ward team members post implementation of electronic medication management systems designed to reduce medication administration errors.

Rae-Anne completed her PhD at the Garvan Institute, studying human genome evolution and genetic mutations leading to pancreatic cancer, during which time she was awarded the Lorne Cancer Conference Student Poster Presentation Award, several international travel bursaries, and was selected as a speaker at the Lowy Cancer Symposium. She was a SIEF-Australian Academy of Science Fellow attending the Nobel Laureate Meeting in Lindau, Germany in 2014. Rae-Anne was also part of the team that sequenced the genomes of the world’s most ancient living populations (the Bushmen of Southern Africa’s Kalahari) as well as the Tasmanian Devil and its facial tumour.

Prior to that, she completed her BSc and Masters thesis at the University of Manitoba (Canada) on molecular epidemiological factors leading to HIV resistance in Kenyan Sex Workers. Most recently, Rae-Anne was awarded an ECR grant to adapt a novel tissue explant model to test prostate cancer drugs on patient tumours ex vivo, as part of her work as a post doctoral Research Officer in the Origins of Cancer Program at the Centenary Institute/Sydney University.